Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.
Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check4 days agoChange DetectedDifference2%
- Check11 days agoChange DetectedSeveral links related to genetic conditions and rare diseases have been removed, including those for Ewing sarcoma, neuroblastoma, and glioblastoma, which may impact access to important information on these topics.SummaryDifference6%
- Check19 days agoChange DetectedNew resources related to various cancers, including Ewing sarcoma, neuroblastoma, and glioblastoma, have been added to the website, enhancing information availability on rare diseases.SummaryDifference1%
- Check26 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
- Check33 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference1%
- Check41 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.8%
Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.